• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

Introduction to 2-cyanophenylzinc bromide (CAS No. 131379-17-4)

2-cyanophenylzinc bromide, identified by the Chemical Abstracts Service Number (CAS No.) 131379-17-4, is a specialized organometallic compound that has garnered significant attention in the field of synthetic chemistry and pharmaceutical research. This compound, featuring a phenyl ring substituted with a cyano group and coordinated to a zinc center via a bromide counterion, exhibits unique reactivity that makes it a valuable intermediate in organic synthesis. Its structure and properties have been thoroughly investigated for applications in cross-coupling reactions, particularly in the development of novel pharmaceuticals and advanced materials.

The structure of 2-cyanophenylzinc bromide consists of a zinc atom bonded to a cyanophenyl group, where the cyano (-CN) moiety enhances the electrophilicity of the aromatic ring. This feature is particularly useful in facilitating various coupling reactions, such as Suzuki-Miyaura and Heck reactions, which are pivotal in constructing complex molecular architectures. The presence of the zinc bromide moiety further influences the compound's stability and reactivity, making it an attractive choice for researchers seeking efficient synthetic routes.

In recent years, organometallic compounds like 2-cyanophenylzinc bromide have been extensively studied for their role in pharmaceutical synthesis. The ability to introduce aryl groups selectively into molecular frameworks is crucial for drug development, where specific chemical entities can modulate biological activity. For instance, researchers have leveraged this compound to synthesize novel heterocyclic compounds that exhibit potential therapeutic effects. The cyano group's influence on electronic properties and its ability to participate in further functionalization make it an indispensable tool in medicinal chemistry.

One of the most compelling aspects of 2-cyanophenylzinc bromide is its utility in cross-coupling reactions, which are fundamental to modern synthetic organic chemistry. These reactions allow for the formation of carbon-carbon bonds under mild conditions, often using palladium or nickel catalysts. However, alternative approaches using zinc-based reagents have emerged as promising alternatives due to their cost-effectiveness and reduced environmental impact. The bromide ligand's role in stabilizing the zinc center while maintaining reactivity has been well-documented, enabling efficient transformations.

Recent advancements in pharmaceutical research have highlighted the importance of 2-cyanophenylzinc bromide in developing small-molecule drugs. For example, studies have demonstrated its use in constructing biaryl structures, which are prevalent in many bioactive compounds. The compound's ability to facilitate regioselective coupling reactions has opened new avenues for designing molecules with tailored biological activities. Additionally, its application in synthesizing complex natural products has been explored, underscoring its versatility.

The synthesis of 2-cyanophenylzinc bromide typically involves the reaction of phenylacetonitrile with zinc dibromide under controlled conditions. This process requires careful optimization to ensure high yields and purity. Recent improvements in synthetic methodologies have focused on enhancing reaction efficiency and minimizing byproduct formation. Such advancements are critical for large-scale applications where cost and sustainability are major considerations.

In conclusion, 2-cyanophenylzinc bromide (CAS No. 131379-17-4) represents a significant advancement in organometallic chemistry with broad implications for pharmaceutical and materials science. Its unique reactivity and structural features make it an indispensable tool for synthetic chemists aiming to develop innovative molecular architectures. As research continues to uncover new applications, this compound is poised to play an even greater role in shaping the future of chemical synthesis.

• 1383429-83-1(2,6-Dimethylphenylzinc bromide)
• 345959-41-3(Zinc, bromo(2-methylphenyl)-)
• 476167-07-4(ZINC, BROMO(3-CYANOPHENYL)-)
• 906100-57-0(ZINC, BROMO(2,4,6-TRIMETHYLPHENYL)-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)